Date: 26–28 August 2026
Venue: Kuala Lumpur Convention Center, Kuala Lumpur, Malaysia
Booth No: H4 . 4078
Fanttest cordially invites global distributors, healthcare professionals, and industry partners to visit us at Booth H4 . 4078. Our experienced sales and technical teams will provide on-site product demonstrations, professional technical consultations, and tailored cooperation solutions, with the goal of creating sustainable, mutually beneficial business opportunities across the ASEAN market.
Backed by our own standardized manufacturing facilities and comprehensive international regulatory certifications, Fanttest provides integrated IVD solutions designed to meet diverse market needs. Combined with our self-developed colloidal gold readers and matched reagent kits, our locally adapted testing systems effectively address key healthcare challenges in Southeast Asia, including limited access to standardized testing equipment, insufficient screening options, and regional supply chain instability.
At this exhibition, we present a well-structured product portfolio covering mature mainstream applications, essential year-round screening needs, and newly upgraded, high-value niche solutions—fully aligned with the public health and clinical testing requirements of Southeast Asia.
Proven through long-term market validation, our tropical epidemic detection products maintain stable and reliable performance. Widely applied in public screening, border inspection and grassroots clinical scenarios, this mature lineup features high market recognition and continuous repurchase demand, serving as a steady revenue pillar for regional partners.
Covering multi-scenario institutional rapid diagnosis, our respiratory combo panels are designed for year-round use across diverse healthcare settings. Compatible with our self-developed reading devices, the series standardizes clinical detection and facilitates daily health monitoring, supporting partners’ long-term and stable market operation.
Tailored for regional gastrointestinal infection screening needs, this product series fits grassroots clinics, community health stations and private medical institutions. With stable clinical performance and broad market coverage, it supplements partners’ product matrix and generates recurring order demand.
Our multi-drug rapid test portfolio is designed for applications in public security, workplace screening, and medical institutions. Targeting underserved niche markets with relatively limited competition and high value-added potential, the series offers forward-looking global partners new opportunities for revenue growth and differentiated market positioning.
Fanttest offers comprehensive strengths as a reliable long-term partner. Supported by stable mass-production capabilities, extensive regulatory compliance across target markets, and multilingual regional customization services, we are committed to ensuring consistent global supply and facilitating smooth market entry for our partners.
As a key healthcare hub in the ASEAN region, Malaysia presents significant growth potential for the IVD market. Driven by technological innovation and localized healthcare empowerment, Fanttest is committed to strengthening tropical disease diagnostic solutions, optimizing regional supply chains, and forging long-term strategic partnerships that contribute to sustainable growth across Southeast Asia’s healthcare and IVD sectors.
